Musculoskeletal Disorders
Conference Coverage
VIDEO: TNF inhibitors don’t boost cancer risk in JIA
WASHINGTON – Tumor necrosis factor inhibitors don't appear to confer any additional cancer risk upon children with juvenile idiopathic arthritis...
From the Journals
Most children with JIA get different diagnosis as adults
Two-thirds of children diagnosed with juvenile idiopathic arthritis are classified later as having a different form of arthritis as adults, with...
News
SHARE initiative releases consensus-based JDM management recommendations
Early and aggressive therapy may prevent or stabilize organ damage and disease-related complications in patients with juvenile dermatomyositis (...
Conference Coverage
VIDEO: TNF inhibitors improved refractory skin disease in juvenile dermatomyositis
Key clinical point: TNF inhibitor treatment in patients with juvenile dermatomyositis may be beneficial for skin involvement that is refractory to...
Conference Coverage
European initiative unveils pediatric care recommendations
Conference Coverage
EULAR-PReS guidelines aim to aid pediatric to adult care transition
Conference Coverage
NSAIDs work best in selected systemic JIA kids
Key clinical point: Three clinical parameters identified the children with systemic juvenile idiopathic arthritis who historically responded best...
Conference Coverage
Adolescent knee pain ‘not benign,’ linked to later OA
Key clinical point: Knee pain in adolescence was directly linked to later development of knee osteoarthritis. Major finding: Adolescent knee pain...
Conference Coverage
Risk of arthritis in children with Down syndrome higher than previously reported
Key clinical point:A musculoskeletal assessment should be part of the annual surveillance for all children with Down syndrome to look for...
News
Lupus patients’ transition to adult care leaves gaps, delays in care
Key clinical point: Lupus patients undergoing transition need better education on the importance of prompt follow-up care with adult...